Trial Profile
Retrospective study to analyze the clinical outcomes of botulinum toxin for chronic temporomandibular disorders
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2018
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- 27 Feb 2018 New trial record